The Department of Justice Bureau of Prisons is forecasting a recompete procurement for hematology analyzer reagents and supplies to support the U.S. Medical Center for Federal Prisoners in Springfield, Missouri. This Blanket Purchase Agreement will provide in vitro diagnostic substances, reagents, and test kits necessary for clinical laboratory operations, specifically supporting the facility's hematology analysis capabilities. The solicitation is estimated to release on July 1, 2027, with an anticipated award date of the same date.

The estimated award value for this opportunity ranges from $425,001 to $450,000 under a firm-fixed-price Blanket Purchase Agreement structure. Performance will be conducted in Springfield, Missouri, with an anticipated contract length exceeding a base period plus four option periods. Interested parties should direct inquiries to Contracting Officer Derek Ramsey at dramsey1@bop.gov or (417) 837-1700, or to Sarah Dean at s3dean@bop.gov.

This recompete builds upon the existing Blanket Purchase Agreement (Contract Number V797D40235-15B41423A00000037), which was awarded to Sysmex America, Inc. on October 1, 2023, with a ceiling value of $764,692.80 and ultimate completion date of September 30, 2026. The current BPA, established against the GSA Federal Supply Schedule for Critical Analyzers, Laboratory (FSS-66-III), provides for the procurement of two 6-part differential hematology analyzers along with all required clinical materials and associated services to support the Medical Center's laboratory testing capabilities.

Analyzer reagents annual

Forecast facts

About this forecast

Forecast text

Work this forecast